Skip to content

The Effectiveness of Virtual Reality on Anxiety Reduction in Women Undergoing Elective Egg Cryopreservation.

Virtual Reality (VR)-Based Intervention to Improve Pre-operative Anxiety in Patients Undergoing Elective Oocyte Cryopreservation: a Randomized Clinical Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06280222
Acronym
VRFORANXIETY
Enrollment
30
Registered
2024-02-28
Start date
2023-11-15
Completion date
2025-02-01
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety

Brief summary

A randomized trial assessing the effectiveness of virtual reality exposure prior to an oocyte retrieval procedure in terms of anxiety level .

Detailed description

Eligible women, undergoing elective egg freezing, will be offered to participate in the study, and sign a consent form. The patients will be randomized into 2 groups: 1. No intervention (routine management). 2. Exposure to scenery video, as a VR (virtual reality) session. All women will be addressed prior to the procedure, while they are waiting, and upon consent will be asked to state their VAS (visual analogue scale) anxiety score and to fill the STAI (The State-Trait Anxiety Inventory questionnaire.) Vital signs (Heart rate, Blood pressure) will be recorded upon arrival. Patients who were allocated to the VR arm will watch a 20-minute scenery video and following the session before entering the procedure will be asked to rate their VAS score and answer the STAI questionnaire once again. vital signs will be recorded again. After recovery all women will fill the STAI questionnaire, VAS score and vital signs before they will be discharged.

Interventions

DEVICEThe VR instrument - Oculus Quest 2

Patients in the interventional group will watch 20-minute scenery movies in the VR instrument before entering the oocyte retrieval procedure.

Sponsors

Hadassah Medical Organization
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* Patients before egg retrieval for social reasons (elective egg freezing)

Exclusion criteria

* Use of any medications for pain relief/ anti -anxiety /anti -depressants medication generally or prior to the intervention * If suffers from any condition that Use of VR is not recommended: 1. Risk for seizures 2. Sensitivity to flashing light/motion 3. Predisposing to nausea/dizziness (vertigo, etc.) Any injury to the eyes/face/neck that would limit the use of the hardware, including blindness.

Design outcomes

Primary

MeasureTime frameDescription
Vital signsUp to 8 hours from admission. (Admission, pre-procedural, discharge)Blood pressure (systolic+ diastolic levels)
VAS (visual-analogue scale)Up to 8 hours from admission. (Admission, pre-procedural, discharge)VAS anxiety score (1-10), Higher levels indicate higher anxiety levels.
State and Trait Anxiety (STAI) ScoreUp to 8 hours from admission. (Admission, pre-procedural, discharge)The patient's anxiety levels will be assessed using the STAI questionnaire, higher numbers in the questionnaire indicate higher anxiety levels. Levels up to 30 indicate low anxiety, between 30-45 moderate anxiety, more than 46 high anxiety levels.

Countries

Israel

Contacts

Primary ContactAnat Hershko-Klement, M.D
anat.klement@gmail.com+972549170084

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026